Use of Valsartan in Post-Myocardial Infarction and Heart Failure Patients
Left ventricular (LV) dysfunction and/or heart failure (HF) are frequent complications of hypertension and myocardial infarction (MI), placing affected patients at increased risk of significant morbidity and premature death. Given that the renin-angiotensin-aldosterone system (RAAS) is activated and...
Main Authors: | Peter P Liu, Aldo Maggioni, Eric J Velazquez |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publications
2006-03-01
|
Series: | Journal of the Renin-Angiotensin-Aldosterone System |
Online Access: | http://jra.sagepub.com/content/7/1_suppl/19.full.pdf |
Similar Items
-
Use of Valsartan in Post-Myocardial Infarction and Heart Failure Patients
by: Peter P Liu, et al.
Published: (2006-03-01) -
Valsartan in the treatment of heart failure or left ventricular dysfunction after myocardial infarction
by: Naylin Bissessor, et al.
Published: (2007-09-01) -
Sacubitril/Valsartan for heart failure
by: Wenqin Dai, MM, et al.
Published: (2022-06-01) -
Efficacy and safety of sacubitril/valsartan vs. valsartan in patients with acute myocardial infarction: A meta-analysis
by: Pei Yang, et al.
Published: (2022-08-01) -
A systematic review and meta-analysis of sacubitril-valsartan in the treatment of ventricular remodeling in patients with heart failure after acute myocardial infarction
by: Xiaomin Zhou, et al.
Published: (2022-10-01)